AstraZeneca
AZNCF | OTC
$189.90
-$2.60 (-1.35%)
Mar 13, 2026, 9:30 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 29, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 61.27B | 60.83B | 59.5B | 58.53B | 57.3B | 55.44B | 54.03B | 51.74B | 48.83B | 47.39B | 45.91B | 45.4B | 44.69B | 43.57B | 43.64B | 44.03B | 43.36B | 41.06B | 38.34B | 34.37B | 31.45B | 29.68B |
Cost of Revenue | 12.7B | 12.34B | 12.95B | 14.53B | 15.7B | 15.17B | 15B | 13.66B | 12.59B | 12.41B | 12.4B | 13.17B | 13.93B | 14.85B | 16.14B | 17.85B | 18.86B | 17.52B | 15.43B | 11.61B | 8.23B | 6.65B |
Gross Profit | 48.57B | 48.48B | 46.54B | 44B | 41.6B | 40.27B | 39.03B | 38.08B | 36.24B | 34.98B | 33.51B | 32.24B | 30.76B | 28.72B | 27.5B | 26.17B | 24.5B | 23.55B | 22.91B | 22.77B | 23.22B | 23.02B |
Operating Income | 13.9B | 14.31B | 13.85B | 12.86B | 12.14B | 11.49B | 10.92B | 10.24B | 9.3B | 8.27B | 7.43B | 7.39B | 6.68B | 5.51B | 3.97B | 3.1B | 1.78B | 2.2B | 3.22B | 4.32B | 5.52B | 5.72B |
Interest Income | 372.52M | 362.82M | 376.11M | 303.59M | 406.98M | 437.48M | 461.06M | 508.62M | 417.3M | 381.73M | 351.2M | 288.32M | 205.36M | 158.04M | 95.32M | 49.16M | 49.75M | 39.25M | 42.66M | 48.87M | 41.16M | 56.33M |
Pretax Income | 12.57B | 13B | 12.58B | 11.58B | 10.21B | 9.41B | 8.68B | 7.97B | 7.68B | 7.39B | 6.92B | 6.82B | 6.1B | 4.22B | 2.46B | 1.01B | -1.82B | -1.3B | -232.32M | 1.61B | 4.42B | 4.63B |
Net Income | 10.43B | 10.45B | 10.37B | 9.51B | 8.45B | 7.86B | 7.03B | 6.54B | 6.39B | 6.29B | 5.97B | 5.94B | 6.16B | 4.67B | 3.21B | 1.92B | -1.24B | -1.05B | 140.56M | 1.53B | 3.8B | 4.01B |
Selling & General & Admin | 20.34B | 19.93B | 18.59B | 17.31B | 16.09B | 16.07B | 15.91B | 16.16B | 16.02B | 16.08B | 15.78B | 14.86B | 14.26B | 13.64B | 14.15B | 13.93B | 13.68B | 12.89B | 11.75B | 11.15B | 11.04B | 11.03B |
Research & Development | 14.66B | 14.56B | 14.25B | 13.87B | 13.37B | 12.71B | 12.2B | 11.69B | 10.92B | 10.63B | 10.3B | 9.98B | 9.82B | 9.57B | 9.38B | 9.15B | 9.04B | 8.46B | 7.95B | 7.29B | 6.66B | 6.27B |
Other Expenses | -326M | -326M | -137M | -37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M | 1M | 1M | 1M |
Operating Expenses | 34.67B | 34.17B | 32.69B | 31.15B | 29.46B | 28.78B | 28.12B | 27.85B | 26.94B | 26.71B | 26.08B | 24.85B | 24.08B | 23.21B | 23.53B | 23.07B | 22.72B | 21.35B | 19.69B | 18.44B | 17.7B | 17.3B |
Interest Expense | 1.74B | 1.76B | 1.73B | 1.66B | 1.7B | 1.69B | 1.74B | 1.78B | 1.68B | 1.67B | 1.64B | 1.56B | 1.5B | 1.37B | 1.33B | 1.28B | 1.29B | 1.32B | 1.29B | 1.28B | 1.28B | 1.29B |
Selling & Marketing Expenses | 442M | 442M | 301M | 148M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 47.37B | 46.51B | 45.65B | 45.67B | 45.16B | 43.95B | 43.11B | 41.51B | 39.53B | 39.13B | 38.48B | 38.01B | 38.01B | 38.06B | 39.67B | 40.93B | 41.58B | 38.86B | 35.13B | 30.05B | 25.93B | 23.95B |
Income Tax Expense | 2.13B | 2.54B | 2.2B | 2.06B | 1.76B | 1.53B | 1.65B | 1.43B | 1.28B | 1.09B | 937.21M | 870.44M | -70.5M | -450.95M | -755.5M | -915.82M | -581.36M | -260.58M | -375.86M | 81.27M | 626.25M | 638.72M |
Shares Outstanding (Basic) | 1.55B | 1.55B | 1.55B | 1.56B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.5B | 1.31B | 1.31B |
Shares Outstanding (Diluted) | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.55B | 1.5B | 1.32B | 1.32B |
EPS (Basic) | 6.71 | 6.73 | 6.67 | 6.11 | 5.44 | 5.07 | 4.53 | 4.22 | 4.12 | 4.06 | 3.85 | 3.83 | 3.98 | 3.01 | 2.08 | 1.24 | -0.84 | -0.65 | 0.30 | 1.32 | 2.89 | 3.06 |
EPS (Diluted) | 6.68 | 6.69 | 6.64 | 6.09 | 5.41 | 5.04 | 4.50 | 4.19 | 4.09 | 4.03 | 3.83 | 3.81 | 3.96 | 3 | 2.06 | 1.23 | -0.84 | -0.65 | 0.30 | 1.32 | 2.89 | 3.06 |
EBITDA | 20.45B | 20.54B | 20.04B | 19.75B | 18.84B | 17.88B | 17.13B | 15.52B | 14.5B | 14.2B | 13.97B | 13.99B | 13.23B | 11.24B | 9.19B | 8.35B | 7.02B | 7.03B | 7.59B | 8.05B | 8.92B | 9.08B |
EBIT | 14.11B | 14.68B | 14.24B | 13.18B | 11.94B | 11.12B | 10.45B | 9.77B | 9.39B | 9.08B | 8.56B | 8.39B | 7.6B | 5.59B | 3.79B | 2.31B | -503.3M | 78.03M | 1.12B | 2.95B | 5.76B | 5.95B |
Depreciation & Amortization | 6.34B | 5.85B | 5.81B | 6.58B | 6.9B | 6.75B | 6.68B | 5.75B | 5.11B | 5.12B | 5.4B | 5.6B | 5.62B | 5.65B | 5.4B | 6.04B | 7.52B | 6.95B | 6.47B | 5.1B | 3.16B | 3.13B |
Add to Watchlist
Select watchlists to add or remove AZNCF